Colour change for insulin injection Fiasp to avoid mix ups with Tresiba

View source ↗

Summary

The EMA announces a colour change for the insulin product Fiasp to help prevent mix-ups with Tresiba, involving visual identifier updates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Fiasp (insulin aspart)
• Tresiba (insulin degludec)